NLRP3 and ischemia: Consistently, some studies showed that inhibition of NLRP-3 inflammasome has reduced the ischemia/recanalization (I/R) injury and protected the BBB in both in vivo and in vitro ischemic conditions (Abulafia et al., 2009; Gao et al., 2017; Bellut et al., 2021).